• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Monoclonal antibody-based ELISA for detection of antibodies against H5 avian influenza viruses

tetano

Editor, Senior Moderator
J Virol Methods. 2012 Nov 19. pii: S0166-0934(12)00386-2. doi: 10.1016/j.jviromet.2012.11.006. [Epub ahead of print]
Monoclonal antibody-based ELISA for detection of antibodies against H5 avian influenza viruses.
Moreno A, Lelli D, Brocchi E, Sozzi E, Vinco LJ, Grilli G, Paolo C.
Source

Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna, Via Bianchi, 9, 25124 - Brescia, Italy. Electronic address: anamaria.morenomartin@izsler.it.
Abstract

Diagnostic and containment measures are essential for the management of avian influenza. In this study, a monoclonal antibody (MAb)-based competitive ELISA for detecting antibodies against H5 avian influenza viruses was developed and validated. Twenty-five anti-H5 MAbs were characterised using competitive, indirect and sandwich ELISAs, immunofluorescence, Western blotting and virus neutralisation and haemagglutination inhibition assays. One MAb (5D8) with wide intra-subtype cross-reactivity was selected and characterised using escape mutant selection. Epitope analysis showed that this MAb recognises a conformational epitope comprising amino acid residues in positions 170, 235 and 240 located in the receptor binding domain. The diagnostic performance of the test was evaluated by ROC analysis using a panel of 950 known sera collected from different avian species, including chickens, turkeys, ducks, pheasants, wild Anseriformes and ostriches. The competitive ELISA had excellent diagnostic performance and discriminatory power with high Se and Sp values (Se:99.6 - 95%CI 98.0-100; Sp:99.4 -95%CI 98.5-99.8). In addition to its excellent diagnostic performance, properties of the competitive ELISA, such as high feasibility of testing sera without pre-treatment and potential for automation and instrument-mediated detection, make it ideal for screening samples, confirming positive HI assay results or analysing samples that are difficult to test using the HI assay.

Copyright ? 2012. Published by Elsevier B.V.

PMID:
23174163
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23174163
 
Back
Top Bottom